Timothy Sullivan

Insider Reports History

Entity
Individual
Location
800 Boylston St., Suite 3310, Prudential Tower C/O Aju Ib Investment, Boston, MA
Signature
/s/ David Watson, attorney-in-fact for Timothy Sullivan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Sullivan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 258K $17.1M $66.30 Apr 1, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Financial Officer Common Stock 79.2K $1.04M $13.19 Apr 18, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Financial Officer Common Stock 70.4K $929K $13.19 Apr 18, 2024 Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023)

Insider Reports Filed by Timothy Sullivan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Apr 18, 2024 2 $0 4 Apr 19, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Apr 1, 2024 3 -$195K 4 Apr 2, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Mar 1, 2024 4 -$319K 4 Mar 5, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 12, 2024 1 -$97K 4 Feb 13, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 1 -$58.1K 4 Jan 31, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$231K 4 Jan 23, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $2.14M 4 Jan 17, 2024 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Nov 30, 2023 4 -$633K 4 Dec 1, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jul 3, 2023 5 -$542K 4 Jul 6, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jun 5, 2023 6 -$5.5M 4 Jun 6, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. May 3, 2023 2 $0 4 May 3, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Apr 19, 2023 2 $0 4 Apr 20, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$57K 4 Feb 22, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2023 1 -$49.9K 4 Feb 14, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$29.1K 4 Jan 30, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$124K 4 Jan 24, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Apr 25, 2022 4 $2.27M 4 Jan 17, 2023 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Feb 10, 2022 1 -$41.2K 4 Feb 14, 2022 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$25.1K 4 Feb 1, 2022 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 Chief Financial Officer
APLS Apellis Pharmaceuticals, Inc. Jun 8, 2021 2 $400K 4 Jun 9, 2021 Chief Financial Officer